News

  1. Aegis Sciences Corporation Achieves HITRUST Risk-based, 2-year Certification Demonstrating the Highest Level of Information Protection Assurance

    HITRUST Risk-based, 2-year (r2) Certification validates Aegis Sciences Corporation continues its commitment to strong cybersecurity and meeting key regulations to protect sensitive data.

  2. The Tip of the Iceberg

    Aegis recent panelist, Ryan S. Alexander, DO, MPH, has released an op-ed where he expresses the need for testing in an uncertain drug landscape.

  3. Xylazine Use Shows Need For Testing

    Aegis provider and recent panelist, Leigh Brooks, APRN, FNP-C, has released an op-ed where she shares her firsthand experience with dangerous drugs like xylazine and how comprehensive testing and education can make an impact.

  4. Testing is Crucial in the Fight Against Xylazine

    Aegis Clinical Pharmacist, Andrew Holt, Pharm.D., BCMAS, CPGx, has released an op-ed where he expresses the importance of clinical definitive testing for fentanyl-xylazine mixtures, an emerging threat to the United States.

  5. Nashville lab ramps up xylazine testing increasingly detected in drug overdoses

    The Biden Administration recently designated the fentanyl-xylazine combination as an emerging national threat. Aegis Sciences Corporation in Nashville has been on the forefront of testing for the deadly compound. Dr. Josh Schrecker, senior director of clinical affairs talked with NewsChannel 5 about how providers utilize test results. Early identification of these compounds is key to appropriate treatment and reduction of overdose risk.

  6. Surveillance and Testing to Stem the Tide of the Next Opioid Drug Crisis

    Aegis recent panelist, Alex J. Krotulski, PhD, released an op-ed that is an exploration into the identification of new and emerging synthetic opioids.

  7. Why Enhanced Confirmation Testing Is Critical To Understanding Nashville’s Drug Landscape and Improving Public Health

    Aegis Clinical Pharmacist, Andrew Holt, Pharm.D., BCMAS, CPGx, has released an op-ed where he touches on Nashville's Drug Landscape, the Role Testing Plays in Identifying Drugs in Patients' Systems, and the Top Illicit Substances Found in Tennessee.